Elicio Therapeutics ELTX
NASDAQ ELTX
$1.57 +0.02 (+1.29%)
At close: Oct 20, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Notes Payables (2020 - 2021)

Updated

Elicio Therapeutics' Notes Payables came in at $895,000 for Q1 2021, down 98.3% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Notes Payables (2020 - 2021) Analysis & Trends

At the end of FY2020, Elicio Therapeutics' Notes Payables was $51.17 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Elicio Therapeutics 29.44 Mn -48.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 895,000.00
Dec 31, 2020 51.17 Mn
API Access

Elicio Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ELTX&period=max&api_key=YOUR_API_KEY